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Low vitamin D status is common globally and is associated with multiple disease outcomes. Understanding the
correlates of vitamin D status will help guide clinical practice, research, and interpretation of studies. Correlates of
circulating 25-hydroxyvitamin D (25(OH)D) concentrations measured in a single laboratory were examined in 4,723
cancer-free men and women from 10 cohorts participating in the Cohort Consortium Vitamin D Pooling Project of
Rarer Cancers, which covers a worldwide geographic area. Demographic and lifestyle characteristics were ex-
amined inrelation to 25(OH)D usingstepwise linearregression and polytomous logistic regression.The prevalence
of 25(OH)D concentrations less than 25 nmol/L ranged from 3% to 36% across cohorts, and the prevalence of
25(OH)D concentrations less than 50 nmol/L ranged from 29% to 82%. Seasonal differences in circulating
25(OH)D were most marked among whites from northern latitudes. Statistically signiﬁcant positive correlates of
25(OH)D included male sex, summer blood draw, vigorous physical activity, vitamin D intake, ﬁsh intake, multivi-
tamin use, and calcium supplement use. Signiﬁcant inverse correlates were body mass index, winter and spring
blood draw, history of diabetes, sedentary behavior, smoking, and black race/ethnicity. Correlates varied some-
what within season, race/ethnicity, and sex. These ﬁndings help identify persons at risk for low vitamin D status for
both clinical and research purposes.
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Abbreviations: ATBC, Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study; CPS-II, Cancer Prevention Study II Nutrition
Cohort; HPFS, Health Professionals Follow-up Study; MEC, Multiethnic Cohort Study; NHS, Nurses’ Health Study; NYU-WHS,
New York University Women’s Health Study; 25(OH)D, 25-hydroxyvitamin D; PLCO, Prostate, Lung, Colorectal and Ovarian
Cancer Screening Trial; SMHS, Shanghai Men’s Health Study; SWHS, Shanghai Women’s Health Study; VDPP, Cohort Con-
sortium Vitamin D Pooling Project of Rarer Cancers.
Vitamin D has established beneﬁts for bone health and
may play a preventive role in other major diseases (1), but
questions persist about what constitutes optimal vitamin D
status. Substantial segments of the population in the United
States and globally have low vitamin D concentrations (2).
Thus, it is important to understand what factors contribute to
concentrations of 25-hydroxyvitamin D (25(OH)D), the ma-
jor circulating metabolite of vitamin D and indicator of
vitamin D status.
The major sources of circulating 25(OH)D include expo-
sure to ultraviolet radiation (ultraviolet B, 280–315 nm) and
dietary and supplemental vitamin D intake. Additional
21 Am J Epidemiol 2010;172:21–35constitutional and behavioral factors can further inﬂuence
25(OH)D status invarious populations. Investigators in mul-
tiple studies have used statistical modeling to examine the
relative contribution of endogenous and exogenous factors
to variation in circulating 25(OH)D levels (2–26), and re-
sults from many of these studies were summarized in
a 2008 International Agency for Research on Cancer report
on vitamin D and cancer (27). Many studies were either
small and/or lacked diversity by geographic location, age,
sex, or race/ethnicity, precluding examination of a broad
range of determinants according to speciﬁc subpopulations
such as race/ethnicity and season of blood collection.
For example, approximately half of the studies involved
European countries at latitudes greater than or equal to
50 N, which is further north than anywhere in the conti-
nental United States (2–5, 8–9, 12–16, 24, 26).
In this report, we examine the correlates of circulating
25(OH)D in the large control population of the Cohort
Consortium Vitamin D Pooling Project of Rarer Cancers
(VDPP). This is a geographically and demographically di-
verse group of men and women, including participants from
US, Finnish, and Chinese cohort studies, with information
on numerous factors affecting vitamin D status.
MATERIALS AND METHODS
Study design and population
Study subjects included 4,723 control participants (2,588
female and 2,135 male) from the VDPP (28). Brieﬂy, in-
vestigators in the VDPP assayed serum or plasma samples
collected prospectively in 1974–2006 for 25(OH)D and ex-
amined its association with 6 cancers (endometrial, gastric/
esophageal, kidney, ovarian, pancreatic, and non-Hodgkin
lymphoma), using a matched nested case-control design
(28). The cohorts included in the present analysis were the
Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study
(ATBC), the Cancer Prevention Study II Nutrition Cohort
(CPS-II), CLUE II (named for the slogan ‘‘Give us a Clue
to Cancer and Heart Disease’’), the Health Professionals
Follow-up Study (HPFS), the Multiethnic Cohort Study
(MEC), the New York University Women’s Health Study
(NYU-WHS), the Nurses’ Health Study (NHS), the Pros-
tate, Lung, Colorectal and Ovarian Cancer Screening Trial
(PLCO), the Shanghai Men’s Health Study (SMHS), and the
Shanghai Women’s Health Study (SWHS). Investigators in
each cohort study received institutional review board
approval from their home institution(s) to participate in
the VDPP.
Measurement of circulating 25(OH)D
All plasma/serum samples were measured for 25(OH)D
at Heartland Assays, Inc. (Ames, Iowa), using the DiaSorin
LIAISON 25(OH) Vitamin D TOTAL Assay (29) as de-
scribed in detail elsewhere (28). Batches were analyzed by
cohort and included masked vitamin D standards provided
by the National Institute of Standards and Technology.
Interbatch coefﬁcients of variation for these standards
were 12.7% and 13.6% for level 1 (~60 nmol/L) and level
2( ~35 nmol/L) standards, respectively (28).
Correlates
Covariate data obtained closest to the time of blood draw
in each cohort were cleaned and harmonized. The following
potential correlates of circulating 25(OH)D were examined:
alcohol use (current use, no current use, or missing data);
body mass index (weight (kg)/height (m)
2), both continuous
and categorical (<25, 25–<30,  30, or missing data); edu-
cation (less than high school, completion of high school,
vocational school, some college, college graduation, or
graduate study); postmenopausal hormone replacement
therapy (no current use, current use, or missing data); his-
tory of diabetes (no, yes, or missing data); history of high
blood pressure (no, yes, or missing data); physical activity
(sedentary, light activity, moderate activity, vigorous activ-
ity, or missing data); race/ethnicity (white, black, Asian,
other, or missing data); smoking status (never smoker, for-
mer smoker, or current smoker); and season of blood draw
(winter (January–March), spring (April–June), summer
(July–September), or fall (October–December)). Potential
dietary determinants of 25(OH)D concentration included
vitamin D intake (IU/day, continuous), calcium intake
(mg/day, continuous), milk intake (g/day, continuous), dairy
food intake (g/day, continuous), ﬁsh intake (g/day, continu-
ous), use of calcium supplements (no current use, current
use, or missing data), and use of multivitamin supplements
(no current use, current use, or missing data). Nutrient levels
were energy-adjusted using the residuals method (30). In-
formation on use ofindividual vitamin D supplements (apart
from multivitamin supplements) was not available; how-
ever, the prevalence of use of vitamin D-speciﬁc supple-
ments was less than 2% among ambulatory US adults in
the 1990s (31).
Subanalyses were conducted among 4 cohorts for which
investigators quantiﬁed doses of total vitamin D (dietary
intake plus supplemental vitamin D, continuous) and total
calcium (dietary intake plus supplemental calcium, contin-
uous) and among 5 cohorts for which there was detailed
information on eye color (blue, green/gray, brown/black,
or missing data) and hair color (red, blond/light brown,
brown/black, or missing data). Information on skin tone
was available for only 2 cohorts, so this was not examined.
Statistical analysis
The differences in circulating 25(OH)D were examined by
season, stratiﬁed by race/ethnicity and, where possible, lati-
tude of residence. Analysis of variance was used to test
whether the mean 25(OH)D concentration within season of
blood draw varied by latitude (<35 N, 35 N– 4 2  N,
or >42 N) or across seasons within each racial/ethnic
and latitude group. Participant characteristics were deter-
mined according to the following 25(OH)D cutpoints: <25,
25–<37.5,37.5–<50,50–<75,75–<100,and 100nmol/L,
corresponding tocommon cutpoints used inthe literatureand
in the VDPP site-speciﬁc analyses (28, 32–34).
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gression coefﬁcients of correlates with continuous 25(OH)D
as the outcome variable. Visual inspection of the residual
Q-Q plot from the linear regression model of circulating
25(OH)D suggested departure from normality by the resid-
uals. Using the Box-Cox procedure (35), the square-root
transformation was chosen. Models with transformed and
untransformed results were similar; therefore, for ease of
interpretation, only the results from models using the non-
transformed 25(OH)D data are presented. A backward step-
wise procedure was used, allowing only variables with
a P value less than or equal to 0.10 for at least 1 category
to remain in the model, while retaining age, sex, cohort, and
season. Stepwise procedures were conducted for all cohorts
combined, for US-only cohorts, and stratiﬁed by sex, race/
ethnicity, and season. Overall P values for categorical vari-
ables were calculated using the Type III Sum of Squares
feature from the Proc GLM procedure in SAS (SAS Institute
Inc., Cary, North Carolina).
Predictors of ‘‘very low’’ (<25 nmol/L), ‘‘low’’ (25–50
nmol/L), and ‘‘higher’’ ( 75 nmol/L) 25(OH)D concentra-
tions were examined using multivariate polytomous logistic
regression. The control group category of 50–<75 nmol/L
was chosen to correspond with our site-speciﬁc analyses
(28). Participants with missing information on diet (n ¼
258) were excluded from stepwise and polytomous regres-
sion models. All statistical analyses were conducted using
SAS, version 9.1.3 or 9.2. Figures were created using R (R
Foundation for Statistical Computing, Vienna, Austria
(http://www.r-project.org/)).
RESULTS
Participating VDPP cohorts and control characteristics
are presented in Table 1. All participants were adults; the
majority were over age 50 years. In most cohorts, blood
samples were collected throughout the year, except CLUE
II, in which samples were collected from May to November,
and ATBC, in which only 7% of samples were collected
during June and August and none were collected in July.
Participants came from Finland, Shanghai, China, and all
major geographic regions of the United States. Seventy-two
percent of participants were white, 4% were black, 18%
were Asian, and 4% were of other race/ethnicity. In the
ATBC, SMHS, and SWHS cohorts, approximately 20% of
the population or more had very low 25(OH)D levels (<25
nmol/L). In the CLUE II, CPS-II, and HPFS cohorts, more
than 20% of the population had 25(OH)D concentrations
greater than or equal to 75 nmol/L.
Figure 1 illustrates the unadjusted distributions of circu-
lating 25(OH)D by country. Vertical lines show cutpoints
used in the analyses. The distribution of 25(OH)D concen-
trations was slightly higher among men in the United States
(Figure 1, part A) and China (Figure 1, part B) than among
women in these countries. The median 25(OH)D levels
among men and women in the United States were 58.4
nmol/L and 51.7 nmol/L, and in China they were 38.0
nmol/L and 33.1 nmol/L, respectively. The ATBC Study,
which included only Finnish men, had the lowest vitamin
D status of all cohorts (median concentration, 31.9 nmol/L)
(Figure 1, part C).
Figure 2 illustrates the distribution of circulating
25(OH)D by race/ethnicity, season of blood draw, and lati-
tude. In whites (Figure 2, part A), 25(OH)D concentrations
were lowest in all seasons among persons living at latitudes
greater than 42 N and highest among those living at lati-
tudes lower than 35 N. The amplitude of seasonal differ-
ences was most marked among whites living in the North,
although seasonal differences were statistically signiﬁcant
in each latitude stratum. In blacks (n ¼ 188; Figure 2, part
B), mean concentrations did not vary within season by 2
latitude strata, except that those living in the South
(<35 N latitude) had borderline-signiﬁcantly different cir-
culating 25(OH)D according to season (P ¼ 0.06). Among
Asians (n ¼ 871) and persons of ‘‘other’’race/ethnicity (n ¼
188) (Figure 2, part C), statistically signiﬁcant differences in
circulating 25(OH)D were observed by season; these sub-
groups could not be examined by latitude because of a lack
of geographic diversity.
Table 2 provides unadjusted summary data for potential
correlates analyzed according to a priori 25(OH)D cut-
points. Higher percentages of black and Asian participants
had 25(OH)D concentrations less than 25 nmol/L as com-
pared with whites and persons of ‘‘other’’ race/ethnicity.
The prevalence of 25(OH)D concentrations less than 25
nmol/L was highest among persons who had had blood
drawn in the winter. Circulating 25(OH)D concentrations
also varied by alcohol consumption, body mass index, use
of hormone replacement therapy, education, history of di-
abetes, history of hypertension, cigarette smoking, physical
activity, and use of nutritional supplements.
Results from the stepwise regression models are pre-
sented in Table 3. Variables positively associated with cir-
culating 25(OH)D concentrations among all controls were
male sex, summer blood draw (vs. fall), vigorous physical
activity (vs. light activity), current alcohol use (vs. none),
vitamin D intake, ﬁsh intake, and current use of calcium and
multivitamin supplements (vs. no current use). Variables
associated with lower circulating 25(OH)D were body mass
index, winter and spring blood draw (vs. fall), history of
diabetes, sedentary physical activity (vs. light activity), cur-
rent smoking (vs. never smoking), and black and ‘‘other’’
race/ethnicity (vs. white). Together, these variables ex-
plained 30% of the variation in 25(OH)D concentrations.
Models limited to US-only participants yielded similar ﬁnd-
ings, except that intake of milk (which is fortiﬁed with
vitamin D in the United States) was a predictor while ﬁsh
intake was not (data not shown).
Results from stepwise regression models stratiﬁed by sex
and race/ethnicity are also shown in Table 3. Predictors in
men and women varied slightly: Only the category of obe-
sity (body mass index  30) was associated with signiﬁ-
cantly lower concentrations in men; a linear association
with body mass index was observed among women. Asso-
ciations with physical activity, smoking, vitamin use, and
dietary sources varied between the sexes. In whites, who
comprised 72% of the total sample population, statistically
signiﬁcant predictors were the same as those for the entire
population. Among blacks, only male sex, summer blood
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remained in the model; all were positively associated with
circulating 25(OH)D. Among Asians, male sex, summer
blood draw, and current alcohol use were positively associ-
ated with 25(OH)D concentrations, while winter and spring
blood draw (vs. fall), current smoking, and dietary calcium
and vitamin D intakes were inversely related.
Table 4 presents results from stepwise regression analyses
stratiﬁed by season of blood draw. Male sex and dietary
vitamin D intake were positively associated and body mass
index and black race/ethnicity were inversely associated
with 25(OH)D concentrations in every season. The ad-
justed r
2 value for winter was 32%, whereas the summer
model explained only 16% of the variation in 25(OH)D
concentrations. In the winter, as opposed to the summer
(when sun exposure would be expected to dominate
25(OH)D status), cigarette smoking and a high school edu-
cation were inversely associated with circulating 25(OH)D
concentrations and ﬁsh intake and multivitamin use were
positively associated.
In the subset of 4 cohorts with data on dose of supple-
mental vitamin D and calcium (ATBC, CPS-II, NHS, and
PLCO), both total vitamin D intake (12.7-nmol increase/
1,000 IU) and ﬁsh intake (6.1-nmol/L increase per 100 g)
remained in the model. The Spearman correlation between
25(OH)D and dietary vitamin D intake (all cohorts) was
0.22 (P < 0.0001), and for total vitamin D intake
(4 cohorts) it was 0.29 (P < 0.0001). In the 5 cohorts with
information on hair color and eye color (ATBC, HPFS,
MEC, SMHS, and SWHS), these variables did not remain
in the ﬁnal model, and race/ethnicity remained a statistically
signiﬁcant predictor.
Table 5 displays predictors of 25(OH)D concentrations
for the categories <25, 25–<50, and  75 nmol/L. The sta-
tistically signiﬁcant predictors of very low 25(OH)D con-
centrations (<25 nmol/L) were black race/ethnicity, low
vitamin D intake, female sex, obesity, sedentary behavior,
and winter blood draw. Factors inversely associated with
very low concentrations of 25(OH)D included Asian race/
ethnicity, calcium supplement use, multivitamin use, and
alcohol consumption. Predictors of 25(OH)D concentra-
tions between 25 nmol/L and 49.9 nmol/L were similar to
those for <25 nmol/L, but the associations were weaker.
Vigorous physical activity was positively associated with
higher 25(OH)D concentrations ( 75 nmol/L), while obe-
sity and low dietary vitamin D intake were inversely
Table 1. Characteristics (%) of Participants in the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers, by Cohort
ATBC
(n 5 842)
CLUE II
(n 5 445)
CPS-II
(n 5 402)
HPFS
(n 5 147)
MEC
(n 5 416)
NHS
(n 5 477)
NYU-WHS
(n 5 472)
PLCO
(n 5 794)
SMHS
(n 5 202)
SWHS
(n 5 526)
Total
(n 5 4,723)
Sex
Male 100 35.3 46.5 100 51.9 0 0 48.4 100 0 45.2
Female 0 64.7 53.5 0 48.1 100 100 51.6 0 100 54.8
Age at blood draw,
years
 29 0 0.9 0 0 0 0 0 0 0 0 0.1
30–39 0 5.2 0 0 0 0 6.6 0 0 0 1.1
40–49 0.2 18.2 0 2.0 0 15.1 22.9 0 15.8 26.2 9.2
50–59 60.6 28.3 1.5 24.5 13.9 41.5 41.3 19.5 20.3 25.1 30.8
60–69 39.0 28.8 39.1 32.7 35.8 43.4 29.2 62.0 33.2 48.3 41.7
70–79 0.2 16.0 53.2 40.1 39.4 0 0 18.5 30.7 0.4 15.3
80–89 0 2.7 6.2 0.7 10.8 0 0 0 0 0 1.8
Race/ethnicity
White 100 99.8 98.0 93.9 12.5 98.3 72.2 92.6 0 0 72.3
Black 0 0.2 0.5 0 24.0 0.4 11.1 3.9 0 0 4.0
Asian 0 0 0.5 0.7 26.2 1.0 0.4 3.0 100 100 18.4
Other 0 0 1.0 2.0 37.3 0.2 4.4 0.5 0 0 4.0
Missing data 0 0 0 3.4 0 0 11.9 0 0 0 1.3
Country of residence
United States
Northeast 0 0 20.6 15.6
a 0 56.2 99.6 12.6 0 0 20.0
Midwest 0 0 29.9 34.7 0 19.3 0 55.2 0 0 14.8
West 0 0 25.4 26.5 100 12.8 0.2 21.2 0 0 16.7
South 0 100 24.1 22.4 0 11.7 0.2 11.1 0 0 15.2
Finland 100 0 0 0 0 0 0 0 0 0 17.8
China 0 0 0 0 0 0 0 0 100 100 15.4
Table continues
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ments, male sex, and summer blood draw were associated
with a borderline-
signiﬁcantly higher likelihood of greater 25(OH)D
concentrations.
DISCUSSION
In this analysis of over 4,700 men and women, low con-
centrations of 25(OH)D were common, especially in China
and Finland. Marked variation in 25(OH)D concentrations
by season of blood draw was seen among whites, especially
for those living in northern latitudes, whereas less striking
seasonal variation was observed in blacks and persons of
‘‘other’’race/ethnicity. Variables that signiﬁcantly predicted
circulating 25(OH)D concentrations included sex, race/
ethnicity, body mass index, alcohol consumption, ﬁsh in-
take, dietary vitamin D intake, season of blood draw, history
of diabetes, physical activity, smoking status, and use of
vitamin D-containing multivitamins and calcium supple-
ments. Participants with higher 25(OH)D concentrations
( 75 nmol/L) tended to be male, to be leaner, to consume
more dietary vitamin D, and to engage in vigorous physical
activity.
The prevalence of very low concentrations of 25(OH)D
(<25 nmol/L) in most US cohorts in this analysis was sim-
ilar to national estimates of approximately 4% in older
adults (36). Exceptions included the MEC, which has large
proportions of African Americans and Japanese Americans,
and NYU-WHS, which includes only women living at
a higher latitude and in a city (New York) where ultraviolet
light exposure may be further limited by tall buildings that
block sunlight. The prevalence of 25(OH)D concentrations
less than 25 nmol/L was 11% in MEC and 13% in NYU-
WHS. Prevalences of low concentrations were higher in
Finland and China than in the United States. In Finland,
a country at a high northern latitude, 64% of blood samples
were collected in months during which ultraviolet-induced
vitamin D synthesis in the skin is very limited. By contrast,
Asians living at a lower latitude in Shanghai probably ab-
sorb less ultraviolet radiation because of their somewhat
darker skin pigmentation and possibly cultural practices
such as avoiding direct sun exposure and wearing more
Table 1. Continued
ATBC
(n 5 842)
CLUE II
(n 5 445)
CPS-II
(n 5 402)
HPFS
(n 5 147)
MEC
(n 5 416)
NHS
(n 5 477)
NYU-WHS
(n 5 472)
PLCO
(n 5 794)
SMHS
(n 5 202)
SWHS
(n 5 526)
Total
(n 5 4,723)
Latitude, degrees
North
<35 0 0 20.9 25.9 97.4 13.4 0.4 6.8 100 100 29.1
35–42 0 100 52.2 42.2 2.6 56.4 99.6 46.5 0 0 38.9
>42 100 0 26.9 32.0 0 30.2 0 46.7 0 0 32.0
Year of blood draw
1985–1989 100 100 0 0 0 38.4 96.8 0 0 0 40.8
1990–1994 0 0 0 94.6 1.2 61.6 3.2 14.5 0 0 12.0
1995–1999 0 0 38.6 5.4 25.5 0 0 80.0 0 94.3 29.6
2000–2004 0 0 61.4 0 71.4 0 0 5.5 80.2 5.7 16.5
2005 or later 0 0 0 0 1.9 0 0 0 19.8 0 1.0
Season of blood draw
Winter 36.9 0 16.7 15.0 24.0 25.8 26.1 22.4 17.3 21.1 22.7
Spring 27.2 33.3 19.7 27.9 27.9 27.9 19.7 28.2 26.2 22.8 26.2
Summer 10.8 47.0 41.8 34.0 27.9 24.3 24.8 24.2 18.3 15.4 24.9
Fall 25.1 19.8 21.9 23.1 20.2 22.0 29.4 25.2 38.1 40.7 26.3
25-Hydroxyvitamin D,
nmol/L
<25 36.2 3.8 4.2 2.7 11.3 5.7 12.7 4.2 18.8 24.9 14.4
25–<37.5 23.5 9.0 8.7 8.2 16.3 12.4 21.0 14.9 29.7 35.6 18.5
37.5–<50 16.6 16.2 19.2 21.1 22.1 24.5 23.1 24.7 25.2 21.9 21.2
50–<75 18.8 43.6 43.3 42.2 33.4 39.6 31.4 42.7 20.8 15.0 32.3
75–<100 4.2 20.0 18.4 19.7 12.5 14.0 10.0 10.3 5.0 2.7 10.6
 100 0.7 7.4 6.2 6.1 4.3 3.8 1.9 3.3 0.5 0 3.1
Abbreviations: ATBC, Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study; CPS-II, Cancer Prevention Study II Nutrition Cohort; HPFS,
Health Professionals Follow-Up Study; MEC, Multi-Ethnic Cohort Study; NHS, Nurses’ Health Study; NYU-WHS, New York University Women’s
Health Study; PLCO, Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial; SMHS, Shanghai Men’s Health Study; SWHS, Shanghai
Women’s Health Study.
a Percentages do not total 100 for this cohort because of missing data.
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Figure 1. Distribution of circulating 25-hydroxyvitamin D (25(OH)D) concentrations by country within the Cohort Consortium Vitamin D Pooling
Project of Rarer Cancers. A) Distribution of circulating 25(OH)D concentrations among US men and women. Vertical lines represent a priori
cutpoints of 25, 37.5, 50, 75, and 100 nmol/L. 25(OH)D concentrations in men were statistically signiﬁcantly greater than those in
women (P < 0.001). B) Distribution of circulating 25(OH)D concentrations among men and women in Shanghai, China. 25(OH)D concentrations
in men were statistically signiﬁcantly greater than those in women (P < 0.001). C) Distribution of circulating 25(OH)D concentrations among men in
Finland.
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fortiﬁed with vitamin D, incontrast to the United States. The
inclusion of the MEC cohort points out interesting contrasts
between Asian populations in the United States and China
and the potential inﬂuence of location. For example, very
few persons of Japanese ancestry in the MEC (1 out of 109)
had concentrations less than 25 nmol/L, which explains the
lower risk of very low 25(OH)D concentrations among
‘‘Asians’’ after we controlled for cohort (e.g., the SWHS
and SMHS) in the model. Japanese Americans in the
MEC cohort are exposed to more sunlight than Chinese
persons in Shanghai, and they also consume milk fortiﬁed
with vitamin D. The concentration of 25(OH)D that is op-
timal for disease prevention is still undetermined, but con-
centrations of 75 nmol/L or more have been advocated (34,
37). A relatively small proportion of participants had con-
centrations greater than 75 nmol/L, ranging from 3% in
SWHS to 27% in CLUE II, with the latter cohort having
had their blood samples collected between May and
November.
The strongest predictor of very low 25(OH)D concentra-
tions in the present study was race/ethnicity, with blacks
being 9 times more likely than whites to have very low
vitamin D status, which is consistent with the literature (6,
7, 10, 16–18, 27). This ﬁnding is probably due in part to the
higher melanin content of dark skin, which blocks pro-vita-
min D3 formation in the epidermis and dermis (38). Current
multivitamin use was a particularly strong predictor of cir-
culating 25(OH)D among blacks, providing a modiﬁable tar-
get for reducing vitamin D deﬁciency in that population.
Body mass index was an inverse correlate of circulating
25(OH)D in the entire population, which is consistent
with previous reports (27, 39). Whether this is due to dif-
ferences in sun exposure among persons with dif-
ferent body mass indices, increased clearance by a larger
body-fat pool, negative feedback from higher circulating
1,25-dihydroxyvitamin D, or sequestration in fat is uncer-
tain (40, 41). Body mass index was not a correlate of
25(OH)D among blacks and Asians in our sample, which
is consistent with recent studies (18, 23, 42). Differences in
dermal production and sequestration by body fat may
provide one explanation (40), but more research on these
complex relations is needed.
Dietary vitamin D intake and use of vitamin D-containing
multivitamin supplements were strong positive predictors of
25(OH)D concentrations in most subgroups studied, which
Figure 2. Mean circulating 25-hydroxyvitamin D (25(OH)D) concen-
trations by race/ethnicity, season, and latitude within the Cohort Con-
sortium Vitamin D Pooling Project of Rarer Cancers. Circles represent
mean values; bars represent the standard error. A) 25(OH)D concen-
trations among whites (n ¼ 3,415) across seasons, within latitude
categories of <35 N, 35 N–42 N, and >42 N. Differences in mean
concentrations were statistically signiﬁcant for all seasons at each
latitude (for winter, spring, and fall, P < 0.001; for summer, P ¼
0.0082). Seasonal differences within latitude were also statistically
signiﬁcant: for <35 N, P ¼ 0.017; for 35 N–42 N, P < 0.0001; and
for >42 N, P < 0.0001. B) 25(OH)D concentrations among blacks
(n ¼ 188) across seasons, within latitude categories of <35 N and
 35 N. Within-season 25(OH)D did not vary by latitude, but the dif-
ference within latitude across seasons was borderline-signiﬁcant for
latitude <35 N( P ¼ 0.06), whereas no differences across season
were noted for latitude  35 N( P ¼ 0.94). C) 25(OH)D concentrations
among Asians (n ¼ 871) and persons of ‘‘other’’ race/ethnicity (n ¼
188) across seasons. The majority of Asians resided between 35 N
latitude and 42 N latitude; statistically signiﬁcant differences in
25(OH)D concentrations were observed across seasons
(P < 0.0001). The majority of persons of ‘‘other’’ race/ethnicity resided
at <35 N latitude; signiﬁcant differences were observed by season
(P ¼ 0.03).
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supplementation (27, 43–45). Calcium supplements often
contain vitamin D, which probably explains the positive
association between calcium intake and circulating
25(OH)D levels, although calcium may also spare conver-
sion of 25(OH)D to 1,25-dihydroxyvitamin D (46). One
exception was observed for Asians, among whom calcium
and vitamin D intake were inversely related to 25(OH)D
levels, for reasons that are unclear. This association may
have been driven by different factors among Asians living
in China, where supplement use is uncommon and milk is
not fortiﬁed with vitamin D. Although theywere statistically
signiﬁcant predictors, dietary vitamin D intake and total
vitamin D intake were relatively weak correlates of circu-
lating 25(OH)D.
Male sexwas associated with higher circulating 25(OH)D
in the stepwise models and in polytomous regression
models, which is consistent with most previous reports
(27).This may be due towomen’s higher percentage of body
fat (beyond that measured through body mass index) (15),
differences in amount of time spent outdoors, or sun pro-
tection behaviors (47).
Table 2. Distribution of Participant Characteristics According to A Priori 25-Hydroxyvitamin D Category in the
Cohort Consortium Vitamin D Pooling Project of Rarer Cancers
a
No. of
Participants
Mean Serum
25(OH)D,
nmol/L
Serum 25(OH)D Category, nmol/L
<25 25–<37.5 37.5–<50 50–<75 75–<100 ‡100
Mean Value
Age at blood draw, years 58.9 59.7 61.1 62.1 62.0 61.6
Body mass index
b 26.2 26.2 26.4 25.8 25.2 24.5
Vitamin D intake, IU/day 139 164 204 219 242 239
Dietary calcium intake,
mg/day
932 890 938 966 1,011 965
Milk intake, g/day 323 237 254 265 278 293
Fish intake, g/day 32 34 34 32 30 30
Row %
Sex
Male 2,135 49.2 18 17 20 32 10 3
Female 2,588 50.4 12 20 22 33 11 3
Race/ethnicity
White 3,415 52.6 13 15 21 36 12 4
Black 188 41.1 27 26 19 19 5 3
Asian 871 41.1 20 31 23 21 5 1
Other 188 51.7 8 18 22 38 11 2
Education
Less than high school 1,010 41.6 24 25 21 24 5 2
Completion of high school 852 51.7 11 20 21 33 12 3
Vocational school 545 41.8 24 23 21 23 6 2
Some college 1,104 52.2 12 17 20 36 12 3
College graduation 517 56.5 7 11 24 39 14 4
Graduate study 617 58.9 5 11 22 42 16 5
Season of blood draw
Fall 1,240 48.8 14 20 22 32 10 2
Winter 1,070 40.8 26 23 21 23 6 1
Spring 1,236 48.5 15 21 21 30 10 3
Summer 1,175 60.7 4 10 20 43 16 7
Body mass index category
<25 2,178 51.4 14 18 20 32 12 4
25–<30 1,799 49.6 14 18 22 33 10 3
 30 717 45.6 16 21 24 29 8 1
Table continues
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observed in this study have been inconsistently associated
with blood 25(OH)D concentrations in the literature. The
association of alcohol intake with higher vitamin D concen-
trations that we observed in this study has not been seen
consistently in other reports. In 1 study of elderly Ameri-
cans, Jacques et al. (11) observed statistically signiﬁcantly
higher 25(OH)D concentrations with greater alcohol intake,
but in another study of participants aged 49–75 years in
which results were controlled for education and employ-
ment status, Egan et al. (6) did not. Current smoking was
associated with lower circulating 25(OH)D concentrations
in comparison with never smoking, which is consistent with
some (2, 6, 13) but not other (10, 11, 15, 48) studies. How-
ever, no dose-response association was observed by number
of cigarettes smoked per day, and smoking did not remain
in the polytomous regression models. Higher 25(OH)D
concentrations were observed among persons reporting
Table 2. Continued
No. of
Participants
Mean Serum
25(OH)D,
nmol/L
Serum 25(OH)D Category, nmol/L
<25 25–<37.5 37.5–<50 50–<75 75–<100 ‡100
Row %
Physical activity
Sedentary 1,548 44.2 20 23 22 26 8 1
Light activity 1,190 49.1 15 17 22 34 10 3
Moderate activity 783 52.4 9 18 22 37 11 3
Vigorous activity 935 56.0 10 15 19 35 15 6
History of diabetes
No 4,352 50.2 14 18 21 32 11 3
Yes 277 44.0 16 29 20 29 5 2
History of hypertension
No 3,308 50.2 15 18 20 33 11 3
Yes 1,357 49.1 13 19 24 32 9 3
Hormone replacement
therapy (women only)
No current use 2,018 49.7 13 21 22 31 11 3
Current use 469 56.2 5 14 23 40 13 4
Smoking status
Never smoker 2,016 51.0 12 19 22 33 12 3
Former smoker 1,380 57.2 5 13 23 41 14 5
Current smoker 1,245 39.6 29 24 18 22 5 2
Alcohol use
No current use 1,938 47.1 16 22 22 29 9 3
Current use 2,470 51.9 13 16 21 35 12 3
Supplemental calcium use
No current use 2,801 49.5 16 18 20 32 10 3
Current use 793 58.1 6 10 23 40 16 4
Multivitamin use
No current use 2,468 49.9 12 20 23 32 10 3
Current use 1,089 59.5 4 11 20 42 17 5
Dietary vitamin D intake,
quintile of IU/day
Quintile 1 753 40.8 24 18 18 28 8 3
Quintile 2 753 47.0 14 18 19 35 11 3
Quintile 3 752 50.2 11 16 22 36 11 3
Quintile 4 753 53.4 9 15 22 36 14 4
Quintile 5 752 57.7 5 11 22 40 17 4
Abbreviation: 25(OH)D, 25-hydroxyvitamin D.
a Summary statistics shown are unadjusted.
b Weight (kg)/height (m)
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Cohort Consortium Vitamin D Pooling Project of Rarer Cancers
a
Total
Sex Race/Ethnicity
Male Female White Black Asian
b P Value b P Value b P Value b P Value b P Value b P Value
No. of controls 4,465 2,023 2,449 3,203 181 867
Adjusted r
2 0.30 0.36 0.26 0.29 0.23 0.31
Male sex (vs. female) 7.85 <0.001 8.20 <0.001 14.70 <0.001 9.01 0.01
Race/ethnicity <0.0001
b 0.0001
b <0.0001
b
White (referent)
Other  6.08 0.004  7.15 0.04  4.74 0.08
Black  13.53 <0.001  11.00 0.001  14.86 <0.001
Asian  0.45 0.837 4.37 0.18  5.12 0.10
Season of blood draw <0.0001
b <0.0001
b <0.0001
b <0.0001
b 0.26
b <0.0001
b
Fall (referent)
Winter  7.13 <0.001  7.89 <0.001  6.31 <0.001  7.54 <0.001 4.27 0.40  8.73 <0.001
Spring  2.18 0.010  2.45 0.05  1.98 0.08  1.90 0.07 5.60 0.24  3.96 0.01
Summer 6.80 <0.001 8.72 <0.001 6.02 <0.001 6.88 <0.001 9.38 0.048 8.52 <0.001
Body mass index
c
Continuous  0.54 <0.001  0.74 <0.001
Categorical 0.07
b <0.0001
b
<25 (referent)
25–<30  0.43 0.67  2.37 0.004
 30  2.96 0.04  7.02 <0.001
Physical activity <0.0001
b 0.002
b <0.0001
b
Sedentary  1.49 0.08  1.83 0.11  1.23 0.20
Light activity (referent)
Moderate activity 0.50 0.62 0.15 0.93 0.59 0.62
Vigorous activity 3.37 <0.001 3.99 0.01 5.07 <0.001
History of diabetes (yes vs. no)  3.67 0.005  3.20 0.07  4.14 0.04  5.29 0.003
Smoking status 0.02
b 0.001
b 0.03
b 0.03
b
Never smoker (referent)
Former smoker 0.05 0.95 0.83 0.41 0.75 0.42  2.70 0.24
Current smoker  3.63 0.003  5.32 <0.001  3.76 0.02  5.31 0.01
Current alcohol use (vs. no current use) 2.46 0.001 3.23 0.01 1.91 0.06 2.43 0.01 3.72 0.07
Dietary calcium intake (per 100 mg)  0.3 0.01 1.9 0.003  0.7 0.04
Dietary vitamin D intake (per 100 IU) 1.8 <0.001 3.5 <0.001 1.8 <0.001  3.1 0.01
Milk intake (per cup (237 mL)) 2.16 <0.001
Fish intake (per ounce (28.4 g)) 0.78 0.02 0.93 0.03
Current use of calcium supplements
(vs. no current use)
4.88 <0.001 4.93 <0.001 5.87 <0.001 5.71 <0.001
Current use of multivitamins
(vs. no current use)
3.65 <0.001 5.69 <0.001 3.67 <0.001 17.56 <0.001
a Results were adjusted for age, and cohort.
b P value for categorical variable.
c Weight (kg)/height (m)
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5vigorous physical activity, driven primarily by associations
in whites and males. A statistically signiﬁcant positive as-
sociation between greater physical activity and 25(OH)D
concentrations was observed in only 3 (7, 17, 23) out of 7
(7, 8, 10, 11, 13, 17, 23) studies. Associations with physical
activity may be a surrogate for greater sun exposure during
outdoor physical activity (25, 49). Finally, a history of di-
abetes was associated with a signiﬁcantly lower 25(OH)D
concentration, even after controlling for body mass index.
Two systematic reviews and meta-analyses have also shown
an inverse association between vitamin D status or intake
and type 2 diabetes or metabolic syndrome (50, 51), al-
though many of the contributing studies, as in this study,
were cross-sectional. This interesting ﬁnding merits further
investigation.
Strengths of this study include the large sample size and
the racial and geographic variability of the population. In
addition, all assays were performed in a single laboratory
using the same method for all assays within a period of 2–3
months. However, only 4% of the sample was black; thus,
more research in this at-risk group is needed. One limitation
was that few investigators had collected detailed information
Table 4. Variables Associated With Circulating 25-Hydroxyvitamin D Concentrations (nmol/L) Among Controls in Stepwise Regression Models
According to Season of Blood Draw, Cohort Consortium Vitamin D Pooling Project of Rarer Cancers
a
Season of Blood Draw
Winter Spring Summer Fall
b P Value b P Value b P Value b P Value
No. of controls 1,015 1,178 1,096 1,188
Adjusted r
2 0.32 0.28 0.16 0.25
Male sex (vs. female) 5.72 0.01 6.93 <0.001 8.98 <0.001 4.04 0.046
Race/ethnicity 0.03
b <0.001
b <0.001
b <0.001
b
White (referent)
Other  5.85 0.14  5.35 0.17  11.51 0.01 3.92 0.38
Black  11.12 0.003  9.23 0.01  15.21 <0.001  16.93 <0.001
Asian  3.06 0.46 8.96 0.05  6.03 0.15 3.20 0.49
Education 0.13
b
Less than high school  3.35 0.21
Completion of high school  4.82 0.05
Vocational school  4.38 0.11
Some college  0.55 0.81
College graduation  2.89 0.27
Graduate study (referent)
Body mass index
c
Continuous  0.63 <0.001  0.74 <0.001
Categorical 0.002
b 0.002
b
<25 (referent)
25–<30  2.13 0.11  1.00 0.44
 30  6.80 <0.001  7.13 <0.001
History of diabetes (yes vs. no)  5.30 0.04  5.08 0.10  5.51 0.02
Smoking status 0.26
b 0.02
b 0.002
b
Never smoker (referent)
Former smoker  0.57 0.72 0.59 0.70 0.47 0.77
Current smoker  4.99 0.047  5.95 0.01  8.56 <0.001
Current alcohol use
(vs. no current use)
2.65 0.06 3.86 0.02 3.31 0.03
Dietary vitamin D intake
(per 100 IU)
2.3 <0.001 2.2 <0.001 2.0 <0.001 1.2 0.03
Fish intake (per ounce (28.4 g)) 2.01 0.002
Current use of multivitamins
(vs. no current use)
5.03 0.003 7.38 <0.001 5.76 0.01
a Results were additionally adjusted for age and cohort.
b P value for categorical variable.
c Weight (kg)/height (m)
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skin tone, or sun sensitivity, which probably accounts for
a considerable proportion of the unexplained variation (i.e.,
~70%) in 25(OH)D concentrations. However, race/
ethnicity, physical activity, and season of blood draw served
as proxies for skin tone and sun exposure to some degree.
Table 5. Odds Ratios for the Association Between Selected Covariates and Circulating 25-Hydroxyvitamin D
Concentrations, Cohort Consortium Vitamin D Pooling Project of Rarer Cancers
a
Serum 25-Hydroxyvitamin D Category
b, nmol/L
<25 25–<50 ‡75
OR 95% CI OR 95% CI OR 95 CI
Sex
Male 1.00 Referent 1.00 Referent 1.00 Referent
Female 4.15 2.57, 6.70 1.70 1.36, 2.12 0.79 0.61, 1.03
Race/ethnicity
White 1.00 Referent 1.00 Referent 1.00 Referent
Black 9.17 4.90, 17.18 2.53 1.60, 4.00 0.83 0.42, 1.64
Asian 0.25 0.07, 0.94 0.97 0.59, 1.59 0.74 0.40, 1.36
Other 1.00 0.44, 2.27 1.10 0.69, 1.77 0.51 0.27, 0.96
Season of blood draw
Fall 1.00 Referent 1.00 Referent 1.00 Referent
Winter 3.23 2.43, 4.30 1.66 1.34, 2.06 0.83 0.60, 1.15
Spring 1.62 1.22, 2.14 1.23 1.01, 1.50 1.04 0.80, 1.37
Summer 0.31 0.21, 0.46 0.65 0.54, 0.80 1.22 0.95, 1.56
Body mass index
c category
<25 1.00 Referent 1.00 Referent 1.00 Referent
25–<30 1.04 0.83, 1.32 1.10 0.94, 1.30 0.78 0.63, 0.95
 30 1.82 1.32, 2.50 1.60 1.29, 1.99 0.58 0.42, 0.80
Physical activity
Sedentary 1.49 1.12, 1.98 1.16 0.95, 1.42 1.07 0.80, 1.41
Light activity 1.00 Referent 1.00 Referent 1.00 Referent
Moderate activity 0.90 0.61, 1.31 0.95 0.76, 1.19 1.01 0.74, 1.36
Vigorous activity 1.12 0.79, 1.61 0.85 0.68, 1.06 1.61 1.23, 2.12
Alcohol use
No current use 1.00 Referent 1.00 Referent 1.00 Referent
Current use 0.61 0.46, 0.80 0.90 0.75, 1.07 1.07 0.86, 1.34
Dietary vitamin D intake,
quintile of IU/day
Quintile 1 4.67 3.12, 7.00 1.63 1.24, 2.14 0.63 0.43, 0.92
Quintile 2 3.28 2.23, 4.84 1.35 1.05, 1.73 0.70 0.51, 0.96
Quintile 3 2.12 1.43, 3.16 1.30 1.02, 1.65 0.71 0.52, 0.95
Quintile 4 1.40 0.93, 2.12 1.27 1.01, 1.61 0.74 0.56, 0.99
Quintile 5 1.00 Referent 1.00 Referent 1.00 Referent
Supplemental calcium use
No current use 1.00 Referent 1.00 Referent 1.00 Referent
Current use 0.38 0.26, 0.56 0.76 0.61, 0.94 1.31 1.01, 1.70
Multivitamin use
No current use 1.00 Referent 1.00 Referent 1.00 Referent
Current use 0.47 0.31, 0.70 0.71 0.58, 0.86 1.19 0.94, 1.50
Abbreviations: CI, conﬁdence interval; OR, odds ratio.
a Results from a polytomous logistic regression model with mutual adjustment for the variables shown. Results
were additionally adjusted for age and cohort.
b Reference category: 50–<75 nmol/L.
c Weight (kg)/height (m)
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iability, including genetic factors (52), is needed. For pool-
ing of the data across cohorts, the level of detail for each
variable was dictated by the cohort with the least detailed
information, prohibiting ﬁner examination of some vari-
ables, such as total vitamin D intake. Although we were
unable to examine the association with individual vitamin
D supplements,their usewas uncommon (31). We examined
correlates of 25(OH)D using a cross-sectional study design.
The extent to which modiﬁcation of these variables would
lead to changes in 25(OH)D is uncertain. In general, partic-
ipants in cohort studies are more educated and of higher
socioeconomic status than members of the general popula-
tion; thus, results from this study are generalizable to similar
populations. Even in this large pooled study of data from 10
cohorts, relatively few persons had very high concentrations
of vitamin D, limiting investigation of correlates of high
concentrations.
Understanding the correlates of vitamin D status has clin-
ical, research, and public health applications. This informa-
tion can help clinicians identify persons most at risk for
vitamin D deﬁciency, who can then be screened and treated
if necessary. As Table 4 shows, blacks, females, the obese,
persons with low vitamin D intake, persons who are phys-
ically inactive, and persons who are not taking supplemental
calcium or multivitamins are much more likely to have
very low concentrations of 25(OH)D. Clinicians checking
vitamin D concentrations during the winter or spring (e.g.,
January–June) will be less likely to overlook insufﬁcient or
deﬁcient 25(OH)D concentrations.
These same risk factors can also be used to select at-risk
individuals for clinical trials, and knowledge of correlates of
circulating 25(OH)D also aids in the analysis and interpre-
tation of observational study results. The markedly higher
prevalence of very low 25(OH)D concentrations in blacks as
compared with whites and among persons living in northern
latitudes during less sunny months supports concern about
vitamin D status in these populations and its possible impact
on health outcomes.
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